GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome

Case Reports in Oncological Medicine
Nagla Abdel KarimZelia M Correa

Abstract

Metastatic prognosis in uveal melanoma is assessed by gene expression profiling (GEP) testing of the tumor cells, usually obtained by fine needle aspiration (FNA). GEP has demonstrated high accuracy in distinguishing class I and II tumors, both having different metastatic potential. Transcriptomic studies identified distinct mutations including somatic mutations in GNAQ and GNA11, detected in more than 80%, and contribute to the upregulation of the mitogen-activated protein kinase (MAPK) pathway and the development of uveal melanoma (UM). The role of these mutations in treatment selection and possible benefit from targeted therapy are somewhat unclear. However, until the discovery of novel agents, local versus systemic therapies remain options for treatment that can still be considered for disease control in certain cases. We report a series of patients with metastatic UM with distinct mutational profiles. One had significant liver metastases with proven GNQ-209P mutation on tissue biopsy while peripheral blood molecular profiling did not show these mutations. The other three cases had no GNQ-209P mutation. All cases received nab-paclitaxel (Abraxane) as a treatment drug, and we record their responses to treatment and their mol...Continue Reading

References

Mar 11, 1976·Journal of the National Cancer Institute·J ScottoJ A Lee
Oct 1, 1992·Molecular and Cellular Biology·G KalinecJ S Gutkind
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P B Schiff, S B Horwitz
Jun 1, 2002·Science·Susana R NevesRavi Iyengar
May 9, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T KiveläS Pyrhönen
Oct 28, 2003·Investigative Ophthalmology & Visual Science·Emma KujalaTero Kivelä
Mar 15, 2005·Ophthalmology Clinics of North America·Arun D SinghStefan Seregard
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Silvin BakalianMiguel N Burnier
Aug 23, 2008·Investigative Ophthalmology & Visual Science·Michael D OnkenJ William Harbour
Dec 17, 2008·Nature·Catherine D Van RaamsdonkBoris C Bastian
Sep 1, 2009·PloS One·Simona LambaAlberto Bardelli
Nov 19, 2010·The New England Journal of Medicine·Catherine D Van RaamsdonkBoris C Bastian
Feb 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithJamie H Von Roenn
Aug 13, 2014·Pigment Cell & Melanoma Research·Jason J LukeRichard D Carvajal
Nov 5, 2015·Expert Review of Anticancer Therapy·Roberto A Leon-Ferre, Svetomir N Markovic
Aug 2, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul J HeskethGary H Lyman
Oct 17, 2017·Clinical Laboratory·Nagla A KarimOla Gaber
Feb 10, 2018·Oncotarget·Nagla Abdel KarimJohn C Morris

❮ Previous
Next ❯

Citations

Sep 3, 2019·Current Topics in Medicinal Chemistry·Fengqian ChenQi Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
biopsy
surgical resection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved